Karamedica Announces National Institute on Aging Grant to Continue Development of Microparticle Therapy for Cerebral Amyloid Angiopathy
15 déc. 2020 07h55 HE
|
Karamedica, Inc.
RALEIGH, N.C., Dec. 15, 2020 (GLOBE NEWSWIRE) -- Karamedica, Inc. recently received a $2.5 million Small Business Innovative Research (SBIR) Phase II grant from the National Institute on Aging to...
Karamedica Announces National Institute of Aging Grant to Develop Microparticle Therapy for Cerebral Amyloid Angiopathy (CAA)
10 oct. 2018 08h00 HE
|
Karamedica, Inc.
RALEIGH, N.C., Oct. 10, 2018 (GLOBE NEWSWIRE) -- Karamedica, Inc., a start-up biomedical company, recently received a Small Business Innovative Research (SBIR) grant from the National Institute of...